The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions

Taj S. Mattu (Lead / Corresponding author), Richard J. Pleass, Antony C. Willis, Mogens Kilian, Mark R. Wormald, Annemarie C. Lellouch, Pauline M. Rudd, Jenny M. Woof, Raymond A. Dwek

Research output: Contribution to journalArticle

308 Citations (Scopus)

Abstract

The human serum immunoglobulins IgG and IgA1 are produced in bone marrow and both interact with specific cellular receptors that mediate biological events. In contrast to IgA1, the glycosylation of IgG has been well characterized, and its interaction with various Fc receptors (FcγRs) has been well studied. In this paper, we have analyzed the glycosylation of IgA1 and IgA1 Fab and Fc as well as three recombinant IgA1 molecules, including two N-glycosylation mutants. Amino acid sequencing data of the IgA1 Fc O-glycosylated hinge region indicated that O-glycans are located at Thr228, Ser230, and Ser232, while O-glycan sites at Thr225 and Thr236 are partially occupied. Over 90% of the N-glycans in IgA1 were sialylated, in contrast to IgG, where <10% contain sialic acid. This paper contains the first report of Fab glycosylation in IgA1, and (in contrast to IgG Fab, which contains only N-linked glycans) both N- and O-linked oligosaccharides were identified. Analysis of the N-glycans attached to recombinant IgA1 indicated that the Cα2 N-glycosylation site contained mostly biantennary glycans, while the tailpiece site, absent in IgG, contained mostly triantennary structures. Further analysis of these data suggested that processing at one Fc N-glycosylation site affects the other. Neutrophil FcαR binding studies, using recombinant IgA1, indicated that neither the tailpiece region nor the N-glycans in the Cα2 domain contribute to IgA1-neutrophil FcαR binding. This contrasts with IgG, where removal of the Fc N-glycans reduces binding to the FcγR. The primary sequence and disulfide bond pattern of IgA1, together with the crystal structures of IgG1 Fc and mouse IgA Fab and the glycan sequencing data, were used to generate a molecular model of IgA1. As a consequence of both the primary sequence and S-S bond pattern, the N-glycans in IgA1 Fc are not confined within the inter-α-chain space. The accessibility of the Cα2 N-glycans provides an explanation for the increased sialylation and galactosylation of IgA1 Fc over that of IgG Fc N-glycans, which are confined in the space between the two Cγ2 domains. This also suggests why in contrast to IgG Fc, the IgA1 N-glycans are not undergalactosylated in rheumatoid arthritis.

Original languageEnglish
Pages (from-to)2260-2272
Number of pages13
JournalJournal of Biological Chemistry
Volume273
Issue number4
DOIs
Publication statusPublished - 23 Jan 1998

Fingerprint

Glycosylation
Fc Receptors
Immunoglobulin A
Polysaccharides
Serum
Immunoglobulin G
Neutrophils
Confined Spaces
Molecular Models

Cite this

Mattu, T. S., Pleass, R. J., Willis, A. C., Kilian, M., Wormald, M. R., Lellouch, A. C., ... Dwek, R. A. (1998). The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. Journal of Biological Chemistry, 273(4), 2260-2272. https://doi.org/10.1074/jbc.273.4.2260
Mattu, Taj S. ; Pleass, Richard J. ; Willis, Antony C. ; Kilian, Mogens ; Wormald, Mark R. ; Lellouch, Annemarie C. ; Rudd, Pauline M. ; Woof, Jenny M. ; Dwek, Raymond A. / The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. In: Journal of Biological Chemistry. 1998 ; Vol. 273, No. 4. pp. 2260-2272.
@article{898df396ded04621a5c542a6b3fc1dec,
title = "The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions",
abstract = "The human serum immunoglobulins IgG and IgA1 are produced in bone marrow and both interact with specific cellular receptors that mediate biological events. In contrast to IgA1, the glycosylation of IgG has been well characterized, and its interaction with various Fc receptors (FcγRs) has been well studied. In this paper, we have analyzed the glycosylation of IgA1 and IgA1 Fab and Fc as well as three recombinant IgA1 molecules, including two N-glycosylation mutants. Amino acid sequencing data of the IgA1 Fc O-glycosylated hinge region indicated that O-glycans are located at Thr228, Ser230, and Ser232, while O-glycan sites at Thr225 and Thr236 are partially occupied. Over 90{\%} of the N-glycans in IgA1 were sialylated, in contrast to IgG, where <10{\%} contain sialic acid. This paper contains the first report of Fab glycosylation in IgA1, and (in contrast to IgG Fab, which contains only N-linked glycans) both N- and O-linked oligosaccharides were identified. Analysis of the N-glycans attached to recombinant IgA1 indicated that the Cα2 N-glycosylation site contained mostly biantennary glycans, while the tailpiece site, absent in IgG, contained mostly triantennary structures. Further analysis of these data suggested that processing at one Fc N-glycosylation site affects the other. Neutrophil FcαR binding studies, using recombinant IgA1, indicated that neither the tailpiece region nor the N-glycans in the Cα2 domain contribute to IgA1-neutrophil FcαR binding. This contrasts with IgG, where removal of the Fc N-glycans reduces binding to the FcγR. The primary sequence and disulfide bond pattern of IgA1, together with the crystal structures of IgG1 Fc and mouse IgA Fab and the glycan sequencing data, were used to generate a molecular model of IgA1. As a consequence of both the primary sequence and S-S bond pattern, the N-glycans in IgA1 Fc are not confined within the inter-α-chain space. The accessibility of the Cα2 N-glycans provides an explanation for the increased sialylation and galactosylation of IgA1 Fc over that of IgG Fc N-glycans, which are confined in the space between the two Cγ2 domains. This also suggests why in contrast to IgG Fc, the IgA1 N-glycans are not undergalactosylated in rheumatoid arthritis.",
author = "Mattu, {Taj S.} and Pleass, {Richard J.} and Willis, {Antony C.} and Mogens Kilian and Wormald, {Mark R.} and Lellouch, {Annemarie C.} and Rudd, {Pauline M.} and Woof, {Jenny M.} and Dwek, {Raymond A.}",
year = "1998",
month = "1",
day = "23",
doi = "10.1074/jbc.273.4.2260",
language = "English",
volume = "273",
pages = "2260--2272",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology",
number = "4",

}

The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. / Mattu, Taj S. (Lead / Corresponding author); Pleass, Richard J.; Willis, Antony C.; Kilian, Mogens; Wormald, Mark R.; Lellouch, Annemarie C.; Rudd, Pauline M.; Woof, Jenny M.; Dwek, Raymond A.

In: Journal of Biological Chemistry, Vol. 273, No. 4, 23.01.1998, p. 2260-2272.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions

AU - Mattu, Taj S.

AU - Pleass, Richard J.

AU - Willis, Antony C.

AU - Kilian, Mogens

AU - Wormald, Mark R.

AU - Lellouch, Annemarie C.

AU - Rudd, Pauline M.

AU - Woof, Jenny M.

AU - Dwek, Raymond A.

PY - 1998/1/23

Y1 - 1998/1/23

N2 - The human serum immunoglobulins IgG and IgA1 are produced in bone marrow and both interact with specific cellular receptors that mediate biological events. In contrast to IgA1, the glycosylation of IgG has been well characterized, and its interaction with various Fc receptors (FcγRs) has been well studied. In this paper, we have analyzed the glycosylation of IgA1 and IgA1 Fab and Fc as well as three recombinant IgA1 molecules, including two N-glycosylation mutants. Amino acid sequencing data of the IgA1 Fc O-glycosylated hinge region indicated that O-glycans are located at Thr228, Ser230, and Ser232, while O-glycan sites at Thr225 and Thr236 are partially occupied. Over 90% of the N-glycans in IgA1 were sialylated, in contrast to IgG, where <10% contain sialic acid. This paper contains the first report of Fab glycosylation in IgA1, and (in contrast to IgG Fab, which contains only N-linked glycans) both N- and O-linked oligosaccharides were identified. Analysis of the N-glycans attached to recombinant IgA1 indicated that the Cα2 N-glycosylation site contained mostly biantennary glycans, while the tailpiece site, absent in IgG, contained mostly triantennary structures. Further analysis of these data suggested that processing at one Fc N-glycosylation site affects the other. Neutrophil FcαR binding studies, using recombinant IgA1, indicated that neither the tailpiece region nor the N-glycans in the Cα2 domain contribute to IgA1-neutrophil FcαR binding. This contrasts with IgG, where removal of the Fc N-glycans reduces binding to the FcγR. The primary sequence and disulfide bond pattern of IgA1, together with the crystal structures of IgG1 Fc and mouse IgA Fab and the glycan sequencing data, were used to generate a molecular model of IgA1. As a consequence of both the primary sequence and S-S bond pattern, the N-glycans in IgA1 Fc are not confined within the inter-α-chain space. The accessibility of the Cα2 N-glycans provides an explanation for the increased sialylation and galactosylation of IgA1 Fc over that of IgG Fc N-glycans, which are confined in the space between the two Cγ2 domains. This also suggests why in contrast to IgG Fc, the IgA1 N-glycans are not undergalactosylated in rheumatoid arthritis.

AB - The human serum immunoglobulins IgG and IgA1 are produced in bone marrow and both interact with specific cellular receptors that mediate biological events. In contrast to IgA1, the glycosylation of IgG has been well characterized, and its interaction with various Fc receptors (FcγRs) has been well studied. In this paper, we have analyzed the glycosylation of IgA1 and IgA1 Fab and Fc as well as three recombinant IgA1 molecules, including two N-glycosylation mutants. Amino acid sequencing data of the IgA1 Fc O-glycosylated hinge region indicated that O-glycans are located at Thr228, Ser230, and Ser232, while O-glycan sites at Thr225 and Thr236 are partially occupied. Over 90% of the N-glycans in IgA1 were sialylated, in contrast to IgG, where <10% contain sialic acid. This paper contains the first report of Fab glycosylation in IgA1, and (in contrast to IgG Fab, which contains only N-linked glycans) both N- and O-linked oligosaccharides were identified. Analysis of the N-glycans attached to recombinant IgA1 indicated that the Cα2 N-glycosylation site contained mostly biantennary glycans, while the tailpiece site, absent in IgG, contained mostly triantennary structures. Further analysis of these data suggested that processing at one Fc N-glycosylation site affects the other. Neutrophil FcαR binding studies, using recombinant IgA1, indicated that neither the tailpiece region nor the N-glycans in the Cα2 domain contribute to IgA1-neutrophil FcαR binding. This contrasts with IgG, where removal of the Fc N-glycans reduces binding to the FcγR. The primary sequence and disulfide bond pattern of IgA1, together with the crystal structures of IgG1 Fc and mouse IgA Fab and the glycan sequencing data, were used to generate a molecular model of IgA1. As a consequence of both the primary sequence and S-S bond pattern, the N-glycans in IgA1 Fc are not confined within the inter-α-chain space. The accessibility of the Cα2 N-glycans provides an explanation for the increased sialylation and galactosylation of IgA1 Fc over that of IgG Fc N-glycans, which are confined in the space between the two Cγ2 domains. This also suggests why in contrast to IgG Fc, the IgA1 N-glycans are not undergalactosylated in rheumatoid arthritis.

UR - http://www.scopus.com/inward/record.url?scp=0031915973&partnerID=8YFLogxK

U2 - 10.1074/jbc.273.4.2260

DO - 10.1074/jbc.273.4.2260

M3 - Article

C2 - 9442070

AN - SCOPUS:0031915973

VL - 273

SP - 2260

EP - 2272

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 4

ER -